A New Dimension in Healing Pets and People
Likarda is a biotech company focused on developing next generation cell-based therapies. We have a patented microencapsulation formulation platform technology which creates injectable cell transplants that stay in the location of delivery. We are starting with the development of this technology for diabetes in dogs and cats, with the goal of replacing daily insulin injections.
Advanced Microencapsulation Technology
For many years, researchers and pharmaceutical companies have been investigating the use of cell-based therapies to treat, or even cure, some of our most debilitating diseases. Microencapsulation enables nutrients, proteins, small-molecules and other essential chemicals to freely diffuse through a hydrogel maintaining cell viability while holding them in a target location in the body. Alginate and alginate-based materials have been the most popular material for use because of desirable manufacturing characteristics. However, time and time again, no matter how many modifications are made to the alginate and its backbone, these formulations typically fail clinically.